Overview

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2028-02-28

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Injection in combination with Chemotherapy and Sequential Thoracic Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer.

Phase:

PHASE2

Details

Lead Sponsor:

The Second Affiliated Hospital of Dalian Medical University

Treatments:

Cisplatin
Etoposide
Radiotherapy